World Stroke Organization calls on public and healthcare professionals to be aware of the risk factors and symptoms of cerebral venous sinus thrombosis (CVST) and its appropriate diagnosis

The symptoms of CVST include headache, blurred vision, loss of control of movement in parts of the body, seizures, fainting, speech difficulties and confusion. It is vital that anyone with suspected CVST receives timely and appropriate neurological assessment and treatment.

SPS commentary:

Diagnosis of CVST requires specialist neurological examination of suspected patients. Brain imaging can be used to confirm the presence of a blood clot or haemorrhage, both of which can occur with CVST.

Rollout of the Johnson & Johnson Covid-19 vaccine has been halted in the US and there have been changes to the clinical guidance on use of the AstraZeneca vaccine in Europe due to the rare occurrence of CVST; safety reviews are ongoing.

Source:

Biospace Inc.